You are using an outdated browser. Please upgrade your browser to improve your experience.
SABCS

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers

SABCS

by San Antonio Breast Cancer Symposium
SABCS
SABCS
SABCS
Apple Watch
SABCS Apple Watch App
SABCS Offers Apple Watch App
Check the details on WatchAware

What is it about?

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS

App Details

Version
1.5
Rating
NA
Size
61Mb
Genre
Reference
Last updated
November 29, 2017
Release date
November 15, 2016
More info

App Screenshots

SABCS screenshot-0
SABCS screenshot-1
SABCS screenshot-2
SABCS screenshot-3
SABCS screenshot-4

App Store Description

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions and forums.

Conference Notes was developed in partnership with AstraZeneca's Digital Innovation Group.